Konu "Alzheimer’s disease" için Scopus İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 1, listelenen: 1-1
-
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
(2023)Abstract Background Alzheimer’s disease (AD) is associated with metabolic abnormalities linked to critical elements of neurodegeneration. We recently administered combined metabolic activators (CMA) to the AD rat model ...